The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

BACKGROUND: Glioblastoma patients show a great variability in progression free survival (PFS) and overall survival (OS). To gain additional pretherapeutic information, we explored the potential of O-(2-(18)F-fluoroethyl)-L-tyrosine (FET) PET as an independent prognostic biomarker. METHODS: We retros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Poulsen, Sidsel Højklint, Urup, Thomas, Grunnet, Kirsten, Christensen, Ib Jarle, Larsen, Vibeke Andrée, Jensen, Michael Lundemann, af Rosenschöld, Per Munck, Poulsen, Hans Skovgaard, Law, Ian
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5281673/
https://ncbi.nlm.nih.gov/pubmed/27554774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3494-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados